Related references
Note: Only part of the references are listed.Hodgkin Lymphoma, Version 2.2022 Featured Updates to the NCCN Guidelines
Richard T. Hoppe et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines
William G. Wierda et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings
Neil Dunavin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group
Anna Waszczuk-Gajda et al.
TRANSPLANTATION PROCEEDINGS (2020)
Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria
Ulrike Binsker et al.
JOURNAL OF INNATE IMMUNITY (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2016)
Prospective Oral Mucositis Audit: Oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European blood and marrow transplantation mucositis advisory group
Nicole Blijlevens et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)